Renee Mueller, MD
Colon & Rectal Surgery · Orlando, FLNPI 1134249386
Payments from drug & device makers
Across 34 payments — averaging $182.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Medtronic$438
- THD America, Inc.$396
- Aroa Biosurgery Incorporated$320
- TELA Bio, Inc.$169
- Cumberland Pharmaceuticals, Inc.$152
- plus $784 from 7 others
What the payments were for
- Travel & lodging$67311%
- Food & beverage$2,52741%
- Education$3,00048%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $3,942 |
| Medtronic(2 entities) | 4 | $438 |
| THD America, Inc. | 3 | $396 |
| Aroa Biosurgery Incorporated | 2 | $320 |
| TELA Bio, Inc. | 3 | $169 |
| Cumberland Pharmaceuticals, Inc. | 3 | $152 |
| Convatec Inc. | 1 | $138 |
| Davol Inc. | 1 | $138 |
| Johnson & Johnson | 2 | $135 |
| Axonics, Inc. | 1 | $133 |
| Smith+Nephew | 1 | $119 |
| Medical Device Business Services, Inc. | 1 | $100 |
| AbbVie | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,654
- Signia$320
- NATURA$138
- Phasix Mesh$138
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$135
- Axonics r-SNM System$133
- Caldolor$122
- PICO$119
- RENASYS TOUCH$119
- Enseal X1 5mm$103
- Echelon Powered Circular$103
- INTERSTIM$100
How this compares
$6,200 in reported general payments places this provider in the 50th percentile of 157 colon & rectal surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 13 | $75 |
| Metronidazole | 14 | $38 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Orlando
- Maria MurphyOrlando$160K
- Ahmed AllawiOrlando$62K
- Teresa Hdebeche-AdamsOrlando$39K
- Marco FerraraOrlando$36K
- Andrea FerraraOrlando$31K
- Antonio CaycedoOrlando$21K
- Norbert Garcia-HenriquezOrlando$15K
- Sergio LarachOrlando$14K
- Mark SolimanAltamonte Springs$887K
- Avraham BelizonBoca Raton$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.